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Topologically homologous four-helix-bundle heme proteins ex-
hibit striking diversity in their refolding kinetics. Cytochrome b562
has been reported to fold on a submillisecond time scale, whereas
cytochrome c refolding requires 10 s or more to complete. Heme
dissociation in cytochrome b562 interferes with studies of folding
kinetics, so a variant of cytochrome b562 (cytochrome c-b562) with
a covalent c-type linkage to the heme has been expressed in
Escherichia coli. Early events in the electron transfer-triggered
folding of FeII-cytochrome c-b562, along with those of FeII-cyto-
chrome c556, have been examined by using time-resolved absorp-
tion spectroscopy. Coordination of S(Met) to FeII occurs within 10
s after reduction of the denatured FeIII-cytochromes, and shortly
thereafter (100 s) the heme spectra are indistinguishable from
those of the folded proteins. Under denaturing conditions, carbon
monoxide binds to the FeII-hemes in 15 ms. By contrast, CO
binding cannot compete with refolding in the FeII-cytochromes,
thereby confirming that the polypeptide encapsulates the heme in
<10 ms. We suggest that Fe-S(Met) ligation facilitates refolding in
these four-helix-bundle heme proteins by reducing the conforma-
tional freedom of the polypeptide chain.
cytochrome  electron transfer  protein folding
Whether topologically similar proteins necessarily have sim-ilar folding pathways is an open question (1). With the
increasing number of structures available, it has become clear
that polypeptide sequences with little or no homology can
assume nearly identical three-dimensional backbone architec-
tures. Theoretical models suggest (2–4), and most experimental
studies confirm (5–8), that a helical bundle is a fast folding
structural motif. The presence of heme cofactors, however, can
introduce new features into the helical bundle energy landscape
that can greatly alter refolding pathways.
We have reported previously on the folding kinetics of two
four-helix-bundle heme proteins, cytochrome b562 (cyt b562) and
cytochrome c (cyt c). Although the two cytochromes have
nearly identical three-dimensional structures (3.4-Å rms devia-
tion of backbone atoms), they have very low sequence identity
(15%) and exhibit quite disparate folding kinetics (9–11). FeII-
cyt b562 folds in less than a millisecond, whereas FeII-cyt c
folding is quite heterogeneous, spanning time scales from mil-
liseconds to seconds. Clearly, topology alone does not dictate
these refolding rates.
The folding of cyt b562 is complicated by heme dissociation
from the polypeptide, limiting the refolding yield (11). We
suggested that heme dissociation could be responsible for the
fast folding observed in cyt b562 by selecting against slower-
folding populations in the unfolded ensemble. Indeed, a recent
investigation of cyt b562 suggests that the heme in the denatured
protein is bound to a native-like polypeptide conformation that
is predisposed to fold rapidly (12).
To circumvent complications arising from heme dissociation,
we have engineered a variant of E. coli cyt b562 (cyt c-b562) in
which two thioether linkages bind the porphyrin to the polypep-
tide chain in the fashion of a c-type cytochrome (13–15). We also
have investigated cytochrome c556 from Rhodopseudomonas
palustris (16), a protein with the same four-helix-bundle fold as
cyt b562 and cyt c (backbone atom rms deviations vs. cyt b562, 3.3
Å; vs. cyt c, 1.5 Å) (17–20) but with low sequence identity (cyt
b562, 21%; cyt c, 34%). Here, we report early events in folding
the FeII forms of c-b562 and c556.
Materials and Methods
Guanidine hydrochloride (GuHCl, Sigma, ultrapure grade),
tris(2,2-bipyridine)ruthenium(II) chloride ([Ru(bpy)3]Cl2,
Strem), and NADH (Sigma) were used as received.
R. palustris cyt c556 was expressed and purified by published
procedures with minor modifications (16). The N-terminal glu-
tamine was fully cyclized by heating the protein at 50°C for 5 h
in 0.5 M KH2PO4 (21). E. coli cyt c-b562 was expressed by
cotransforming the construct pETcb562 (unpublished proce-
dure) with pEC86 (22) into E. coli strain BL21 (DE3). Cyt c-b562
was purified by ion exchange chromatography on CM Sepharose
Fast Flow and followed by a second purification step on a Mono
S column (FPLC, Amersham Pharmacia). Proteins were judged
to be pure by SDSPAGE (PhastSystem, Amersham Pharmacia)
and electrospray ionization–MS analysis (Caltech Protein
Peptide Microanalytical Laboratory).
Circular dichroism (CD) spectra were recorded by using an
Aviv 62ADS spectropolarimeter; Trp fluorescence spectra were
recorded on a Jobin Yvon SPEX Fluorolog-3 spectrofluorimeter
(ex  290 nm; em  300–500 nm). Steady-state absorption
spectra were recorded on a Hewlett–Packard HP-8453 or HP-
8452 diode array spectrometer. Protein (cyt c-b562) concentra-
tions were determined by using the extinction coefficients re-
ported for cyt b562 (23, 24).
Transient absorption kinetics measurements were made as de-
scribed in refs. 11 and 25. Folding measurements were performed
with solutions buffered to pH 7 with cyt c556 and pH 5 with c-b562
to inhibit misligation of His-63. Samples for folding kinetics mea-
surements [cyt c556 or c-b562 (100 M); Ru(bpy)3
2 (50–150 M) or
NADH(200M);GuHCl (1–6M)]were sealed in 1-mmcuvettes
and deoxygenated by repeated evacuationAr orCObackfill cycles.
GuHCl concentrations were determined after laser experiments
from refractive index measurements (Abbe-3L refractometer, Mil-
ton Ray, Rochester, NY) (26).
Results and Discussion
Equilibrium Unfolding. Cyt c556 and c-b562 are soluble proteins
(molecular masses of 14.7 and 12.3 kDa, respectively). Each
folded structure contains four antiparallel -helices in a left-
handed bundle with a heme group located in a hydrophobic
pocket near the C and N termini; the porphyrin is covalently
bound to the polypeptide chain through thioether linkages with
two C-terminal cysteine residues, and the iron center is axially
ligated by Met-12 and His-121 (cyt c556) or Met-7 and His-102
(cyt c-b562) (18). GuHCl titrations, monitored by absorbance,
CD, and tryptophan fluorescence spectra, reveal cooperative
Abbreviation: cyt, cytochrome.
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unfolding transitions (Fig. 1), and, as expected on the basis of
their high reduction potentials, the FeIII forms are less stable
than the FeII proteins (27, 28). It is interesting to note that the
introduction of two thioether linkages to the heme in cyt c-b562
leads to a substantial stabilization of the folded protein (the
denaturation midpoint, [GuHCl]1/2, increases by 2 M).
The absorption spectra of native and denatured FeIII/II-cyt c556
and FeIII/II-cyt c-b562 (pH 5) are shown in Fig. 2. In both FeIII and
FeII oxidation states, the heme becomes exposed to the solvent
upon unfolding, leading to distinct shifts in absorption spectra,
including variations in extinction coefficients, which can be
exploited to monitor folding kinetics. The blue shift in the Soret
absorption upon denaturation of each FeIII protein indicates that
the heme has undergone a low- to high-spin transition, likely the
result of replacement of the axial methionine ligand with a water
molecule. In denatured FeII forms, however, both Soret and
Q-band absorptions suggest that the heme remains low-spin. In
contrast to the behavior of unfolded cytochrome c, it is not likely
that nonnative His coordination accounts for the low-spin hemes
in denatured FeII-cyt c556 and FeII-cyt c-b562. Cyt c556 has no
available His residues, and denaturation of FeII-cyt c-b562 was
performed at pH 5 to inhibit His-63 misligation. As was sug-
gested for unfolded FeII-cyt c, methionine residues apparently
compete for the sixth FeII coordination site in the unfolded
proteins. In FeII-cyt c-b562, both Met-7 and Met-58 are likely to
be involved; Met-12, Met-19, and Met-20, and possibly Met-110,
are the candidates in FeII-cyt c556. Analogous behavior was found
in denaturedR. palustris FeII-cyt cwhereMet-15 andMet-25 are
potential ligands (9, 10). Although the absorption spectra of
denatured FeII-cyt c556 and FeII-cyt c-b562 resemble those of the
folded proteins, CD spectra clearly indicate that the native
helical secondary structures are substantially disrupted (12).
Electron Transfer-Triggered Refolding. At suitable denaturant con-
centrations (cyt c556, 1.5–2.5 M; cyt c-b562 3.8–4.8 M), electron
injection into the denatured FeIII protein will initiate folding of
the FeII form (27). In prior work, we have demonstrated that
Ru(bpy)3
2 and NADH are useful sensitizers for photochemical
triggering of FeII-cytochrome refolding (27, 29). Electronically
excited Ru(bpy)3
2 [E°(Ru3/*2)  0.85 V vs. normal hydro-
gen electrode] injects an electron into the unfolded protein
within a few microseconds. Subsequent charge recombination
regenerates the initial reagent in a few milliseconds, allowing
extensive signal averaging but limiting the observable window for
folding to 1 ms. Two-photon excitation (355 nm) of NADH
produces two reductants (eaq
 and NAD) that irreversibly reduce
the heme group in100 s (100 M protein) (30). Therefore,
with NADH it is possible to expand the observation time window
to seconds and longer.
We have used both Ru(bpy)3
2 and NADH to trigger FeII-cyt
c556 and FeII-cyt c-b562 refolding. In experiments with
*Ru(bpy)3
2 as the photoreductant, the observed transient ab-
sorption kinetics depend on denaturant concentration. These
Fig. 1. Denaturant-induced unfolding of FeIII (green) and FeII (red) c556 (A)
and c-b562 (B). Data points are from CD measurements; data from with heme
absorption and Trp fluorescence are virtually the same. Fig. 2. Absorption spectra of unfolded FeIII (green dashed line), folded FeII (red
dashed line), and unfolded FeII (blue dashed line) cyt c556 (A) and cyt c-b562 (B).
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data are adequately described by a biexponential function. The
faster rate is independent of [GuHCl] and corresponds to decay
of *Ru(bpy)3
2 (k1 1.6 106 s1) with parallel reduction of the
FeIII protein. The rate constant for the slower phase varies with
[GuHCl]; this reaction channel represents early events in the
folding of the protein around the heme (Fe-cyt c556, k2 4 105
to 8 105 s1, [GuHCl]  3–2 M; Fe-cyt c-b562, k2  5 105 to
2 106 s1, [GuHCl]  5.5–4.5 M). The transient spectra
measured at the end of the slower phase (t  100 s) are
consistent with the formation of reduced folded protein.
Biexponential kinetics also are observed when NADH is used
as the photoreductant, with rate constants independent of
[GuHCl] that are attributable to the reduction of the protein by
eaq
 (4–5  104 s1) and NAD (9  103 s1). The relative signal
amplitudes observed after excitation of samples at low and high
[GuHCl] (Fe-cyt c556, 1.5 and 4 M; Fe-cyt c-b562, 4 and 7 M)
suggest that folded reduced protein is formed 300 s after
excitation (Fig. 3). No additional changes in absorption were
detected on time scales as long as several seconds; the formation
of folded reduced protein appears to be limited by the rate of
reduction by NAD. Moreover, steady-state UV-visible and CD
spectra recorded after laser excitation of NADH-containing
samples confirm that the photochemically reduced proteins
adopt native folds.
The transient absorption data suggest that FeII-cyt c556 and
FeII-cyt c-b562 refolding rates are faster than 104 s1. UV-visible
spectra provide information about the immediate environment of
the heme cofactor but do not directly report on the conformation
of the polypeptide. To gain more insight into the submillisecond
FeII-cyt c556 and FeII-cyt c-b562 folding dynamics, we repeated the
photoinitiated refolding experiments in the presence of CO. The
deeply buried iron centers of native c-b562 and c556 are six-
coordinate and therefore not available for CO binding. Under
denaturing conditions, the ferroheme remains low-spin, likely due
to Met ligation in the sixth coordination site. Nevertheless, CO will
replace Met as an FeII ligand in denatured c-b562 and c556. We have
examined the kinetics of CO rebinding to the heme after photo-
dissociation from denatured FeII(CO)cyt c-b562 ([GuHCl]  7 M)
andFeII(CO)cyt c556 ([GuHCl] 4M).Under 1 atm (1 atm 101.3
kPa) of CO, the rate constant for CO rebinding to the FeII heme
is65 s1. We have used CO ligation to the heme as a probe of the
extent of heme protection afforded by the polypeptide during
electron transfer-triggered refolding. If the polypeptide wraps
around the heme rapidly (102 s1), little CO should bind to the
heme. On the other hand, if folding is slower than 102 s1,
substantial CO binding is expected. We find that at 7 M GuHCl,
where formation of native, reduced c-b562 is disfavored, there is a
major change in absorbance consistent with CO binding after
reduction of the FeIII protein. In contrast, very little CO binding is
apparent under conditions favoring formation of the folded FeII-
protein (4 M GuHCl) (Fig. 4).
Our electron transfer-triggered experiments reveal that early
events (t 	 100 s) in FeII-cyt c556 and FeII-cyt c-b562 refolding
involve formation of a low-spin heme and some degree of heme
encapsulation by the polypeptide. A lower limit to the time
required for the heme to ligate a Met residue can be estimated
from studies of tertiary contact dynamics in unfolded proteins
and peptides (31–33). Met ligation to the heme in FeII-cyt c556
will produce polypeptide loops comprised of 96, 97, and 104
residues, and loop sizes of 39 and 90 residues in FeII-cyt c-b562
are possible. Energy-transfer quenching studies in synthetic
polypeptides suggest that tertiary contact rate constants (kc) for
90- to 100-residue loops are 106 to 107 s1 (32). These values
compare with our observed rates of 105 to 106 s1 for formation
of native heme absorption spectra in electron transfer-triggered
FeII-cyt c556 and FeII-cyt c-b562 refolding experiments. The
variation of these rate constants with [GuHCl] concentration is
likely due in part to the viscosity dependence of the intrachain
diffusion dynamics that lead to tertiary contacts. In synthetic
peptides, the logarithms of tertiary contact rates exhibit a linear
dependence on [GuHCl] with mc values {mc  RT(ln(kc))
[GuHCl] 0.5 (kJmol)M} (34) that are substantially smaller
than the mk values {mk  RT(ln(kobs))[GuHCl]} found for
the early kinetics phases of FeII-cyt c556 [2.5 (kJ/mol)M] and
FeII-cyt c-b562 [2.1 (kJ/mol)M] refolding (Fig. 5). Fast-folding
Fig. 3. ET-triggered refolding of FeII-cyt c-b562. (A) Steady-state difference
spectra between folded FeII and unfolded FeIII (red) and between unfolded FeII
and unfolded FeIII (blue) c-b562. Symbols indicate transient absorption changes
measured 300s after 355-nm pulsed-laser excitation of NADH in the presence
of denatured FeIII-cyt c-b562 (red squares, [GuHCl] 4 M; blue circles, [GuHCl]
 7 M). (B) Transient absorption kinetics observed at 556 nm upon reduction
with NADH of c-b562 at 4 M GuHCl (red) and at 7 M GuHCl (blue). (C) Transient
absorption kinetics observed at 548 nm.







small proteins have been reported to have mk values of 1–2
(kJ/mol)M (34). The mk values for larger proteins displaying
two-state refolding kinetics are larger, 5–10 (kJ/mol)M (34).
These denaturant dependences observed for FeII-cyt c556 and
FeII-cyt c-b562 refolding suggest that the early kinetics phases
involve more than intrachain diffusion leading to Met-Fe liga-
tion. Rapid Met-Fe ligation could facilitate refolding of FeII-cyt
c556 and FeII-cyt c-b562, because formation of one or more strong
native tertiary contacts will substantially reduce the size of the
conformational space available to the polypeptide (35). Con-
straining the folding energy landscape in this manner could lead
to a substantial reduction in the time required to find the native
structure (36).
After reduction of the unfolded oxidized proteins, CO will
bind to the ferroheme under solution conditions where for-
mation of native structure is disfavored. The observed rate
constant for CO binding to denatured FeII-cyt c556 and FeII-cyt
c-b562 (65 s1) is10 times smaller than the corresponding rate
found for FeII-cyt c (10), and 20 times smaller than the rate
for FeII-cyt c (37). The smaller CO binding rate constant for
FeII-cyt c556 and FeII-cyt c-b562 may be a consequence of
stronger Met binding to the reduced denatured proteins.
Indeed, the similarity in the absorption spectra of folded and
denatured reduced proteins (Fig. 2) suggests that Met is
completely bound in the denatured forms. The Soret absorp-
tion of denatured FeII-cyt c is less intense than that of
denatured FeII-cyt c556 and FeII-cyt c-b562, possibly because of
less complete Met binding.
Our finding that CO does not bind to the FeII-cyt c556 and
FeII-cyt c-b562 hemes under GuHCl conditions favoring folding
points to encapsulation of the heme by the polypeptide in 	10
ms. The spectroscopic data do not reveal whether the polypep-
tide has developed secondary and tertiary structure by this time.
Ultrafast mixing measurements on a F65W mutant of apo-cyt
b562, which adopts a three-helix-bundle fold (19, 38), are con-
sistent with a refolding rate constant of 2,600 s1 in the absence
of denaturant (12). This value represents a reasonable upper
limit to the folding rate for the holoprotein and is in line with the
lower limit indicated by our CO ligation measurements.
The refolding of FeII-cyt c556 and FeII-cyt c-b562 clearly begins
from an extensively denatured state. This finding contrasts with
recent results on FeII-cyt b562 (12) where, as we had suggested
earlier (11), heme dissociation preselects fast-folding members of
the denatured ensemble. The only events revealed by changes in
heme absorption spectra in FeII-cyt c556 and FeII-cyt c-b562 occur on
very early time scales (1–10 s) and involve Met-Fe ligation
processes. The absence of separate kinetics phases attributable to
heme encapsulation by the polypeptide, and the observation that
the heme is protected from CO binding, confirm that a substantial
degree of refolding occurs on submillisecond time scales. This
behavior contrasts sharply with results from FeII-cyt c experiments
inwhich changes in heme spectrawere observedon time scales from
104 s to 101 s after reduction of the unfolded oxidized protein. We
suggest that formation of one persistent native contact in the early
stages of FeII-cyt c556 and FeII-cyt c-b562 refolding puts each
polypeptide on a fast track to its native structure (36). The slower
and more complex refolding kinetics found for FeII-cyt c may be
a consequence of weaker S(Met)-Fe bonding in the denatured
protein.
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Fig. 4. ET-triggered refolding of FeII-cyt c-b562 in the presence of CO. (A) Transient absorption kinetics observed at 415 nm upon photochemical reduction
(NADH) of c-b562 at 4 M GuHCl (red) and at 7 M GuHCl (pink) (1 atm CO). (B) Difference spectra between folded FeII and unfolded FeIII (red), between unfolded
FeII and unfolded FeIII (blue), and between CO-FeII and unfolded FeIII c-b562 (pink).
Fig. 5. Folding rates as a function of [GuHCl]. Red, FeII-cyt c-b562; blue, FeII-cyt
c556; green, FeII-cyt b562 (11); yellow, FeII-cyt c (the vertical bar reflects the
range of observed rate constants) (10).
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